Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.

Urothelial carcinoma (UC) accounts for 5% to 10% of malignancies in men in Europe and the United States. For locally advanced or metastatic disease, there are two standard firstline chemotherapy regimens: MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) and gemcitabine/cisplatin. For refract...

Полное описание

Библиографические подробности
Главные авторы: Morel, A, Talbot, D
Формат: Journal article
Язык:English
Опубликовано: Dove Medical Press Ltd. 2010

Схожие документы